主治醫師:黃奕文 

主治醫師:黃奕文


現職:
國泰綜合醫院肝臟中心主治醫師
台北醫學大學醫學系內科部定副教授
臺大醫學院醫學系內科部定講師

代碼 05290

人氣 1638





醫務專長

腸胃病變

  • 腹脹、消化吸收不良、食慾不振
  • 腹痛、胃痙攣抽痛
  • 胃痛、潰瘍、黑便
  • 打嗝、嘔酸水、胸口灼熱感、吞嚥困難、吐血
  • 腹瀉、血便、貧血、便秘
  • 胃腸息肉、腫瘤
  • 大腸息肉、腫瘤
 

肝膽胰病變

  • B型肝炎定期追蹤、B型肝炎治療
  • C型肝炎定期追蹤、C型肝炎治療
  • 肝功能異常、易疲勞、膚色變黃
  • 酒精性肝病
  • 脂肪肝
  • 膽結石、膽息肉
  • 肝腫瘤、肝硬化、肝癌
  • 胰臟炎

榮譽及獲獎

  • 美國肝病研究學會會長傑出學術壁報獎
  • 臨床肝膽病雜誌優秀論文獎
  • 台灣消化系醫學會秋季學術演講會學術優秀壁報獎
  • 世界超音波醫學會議青年研究學者獎學金
  • 美國肝病研究學會及亞太肝臟研究學會聯合研究獎
  • 歐洲肝臟研究學會青年研究學者公費獎助
  • 台灣大學研究生學術研究優良獎
  • 日本消化器病學會研究進修獎學金
  • 國際酒精性肝胰病暨硬化會議獎助
  • 基督教國際醫療服務機構服務感謝狀
  • 台灣科技部赴國外研究獎助

學經歷

  • 臺大醫學院臨床醫學研究所博士
  • 美國哈佛醫學院附屬麻州綜合醫院研究醫師
  • 日本廣島大學肝炎研究醫師
  • 日本近畿大學醫學系肝膽胃腸科研究醫師
  • 波蘭西里西亞醫學大學及波茲南醫學科學大學臨床助理教授
  • 中華民國醫用超音波學會會訊主編及學刊編輯委員
  • VIP健康管理中心副主任
  • 臺大醫院內科部住院醫師
  • 新光醫院急診部住院醫師
  • 美國肝病研究學會會員
  • 歐洲肝臟研究學會會員
  • 亞太肝臟研究學會會員
  • 臺灣內科專科醫師及指導醫師
  • 臺灣消化系內科專科醫師及指導醫師
  • 臺灣消化系內視鏡專科醫師
  • 臺灣肝臟研究學會會員
  • 臺灣肝癌醫學會會員
  • 中華民國醫用超音波學會會員臺大醫院胃腸肝膽內科兼任主治醫師
  • 臺大醫院胃腸肝膽科研究醫師
  • 臺大醫院內科部總醫師

論文及學術著作

【個人研究著作】

  • Yi-Wen Huang, Chih-Lin Lin, Pei-Jer Chen, Ming-Yang Lai, Jia-Horng Kao, Ding-Shinn Chen. Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B. Journal of Gastroenterology and Hepatology 2006; 21(5): 859-62.
  • Yi-Wen Huang, Chun-Jen Liu, Ming-Yang Lai, Po-Huang Lee, Meng-Kung Tsai, Shoei-Shen Wang, Ming-Kuen Lai, Jia-Horng Kao. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplant in hepatitis B surface antigen positive patients: a retrospective case series. Clinical Therapeutics 2006; 28(9): 1327-34.
  • Yi-Wen Huang, Chih-Lin Lin, Pei-Jer Chen, Ming-Yang Lai, Jia-Horng Kao, Ding-Shinn Chen. Hepatitis B viral genotype in Taiwanese patients with acute hepatitis B. Hepato-Gastroenterology 2008; 55: 633-35.
  • Yi-Wen Huang, Chung-Yi Hu, Chi-Lin Chen, Ya-Tang Liao, Chun-Jen Liu, Ming-Yang Lai, Pei-Jer Chen, Sien-Sing Yang, Jui-Ting Hu, Ding-Shinn Chen, Jia-Horng Kao. Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus. Journal of Medical Virology 2009;81:588-593.
  • Sien-Sing Yang, Jui-Ting Hu, Yi-Wen Huang, Mei-Yu Hsu, Han-Yu Chang. The study of narrow band imaging system in the evaluation of esophageal varices. Gastroenterology Journal of Taiwan 2009;26:164-169.
  • Yi-Wen Huang, Ya-Tang Liao, Wendy Chen, Chi-Lin Chen, Jui-Ting Hu, Chun-Jen Liu, Ming-Yang Lai, Pei-Jer Chen, Ding-Shinn Chen, Sien-Sing Yang, Jia-Horng Kao. Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan. Genes and Immunity 2010;11:87-93.
  • Yi-Wen Huang, Kazuaki Chayama, Masataka Tsuge, Shoichi Takahashi, Tsuyoshi Hatakeyama, Hiromi Abe, Jui-Ting Hu, Chun-Jen Liu, Ming-Yang Lai, Ding-Shinn Chen, Sien-Sing Yang, Jia-Horng Kao. Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B. Antiviral Therapy 2010;15:177-184.
  • Yi-Wen Huang, Jui-Ting Hu, Sien-Sing Yang. Complications of alcoholic liver cirrhosis: active assessment by endoscopy and sonography. Hepatology 2010;52:1864-1865.
  • Tung-Hung Su, Ching-Sheng Hsu, Chi-Ling Chen, Chen-Hua Liu, Yi-Wen Huang, Tai-Chung Tseng, Chun-Jen Liu, Pei-Jer Chen, Ming-Yang Lai, Ding-Shinn Chen, Jia-Horng Kao. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B. Antiviral Therapy 2010;15:1133-9.
  • Chih-Wen Lin, Yaw-Sen Chen, Chung-Hsu Lai, Daw-Shyong Perng, Hui-Ching Weng, Jui-Ting Hu, Yi-Wen Huang, Mei-Yu Hsu, Sien-Sing Yang. Esophagogastric varices predict mortality in hospitalized patients with alcoholic liver disease in Taiwan. Hepato-Gastroenterology 2010;57:285-9.
  • Yi-Wen Huang, Sien-Sing Yang, Jia-Horng Kao. Pathogenesis and management of alcoholic liver cirrhosis: a review. Hepatic Medicine 2011;3:1-11.
  • Tai-Chung Tseng, Ming-Lung Yu, Chun-Jen Liu, Chih-Lin Lin, Yi-Wen Huang, Ching-Sheng Hsu, Chen-Hua Liu, Stephanie Fang-Tzu Kuo, Corinna Jen-Hui Pan, Sheng-Shun Yang, Chien-Wei Su, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy. Antiviral Therapy 2011;16:629-37.
  • Yi-Wen Huang, Raymond T. Chung. Management of hepatitis B reactivation in patients receiving cancer chemotherapy. Therapeutics Advances in Gastroenterology 2012;5:359-70.
  • Yi-Wen Huang, Jui-Ting Hu, Fu-Chang Hu, Ching-Jui Chang, Han-Yu Chang, Jia-Horng Kao, Sien-Sing Yang, Ding-Shinn Chen. Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients. Antiviral Therapy 2013;18:567-73.
  • Yi-Wen Huang, Shih-Chang Lin, Shu-Chen Wei, Jui-Ting Hu, Han-Yu Chang, Shih-Hung Huang, Ding-Shinn Chen, Pei-Jer Chen, Ping-Ning Hsu, Sien-Sing Yang, Jia-Horng Kao. Reduced Toll-like receptor-3 expression in chronic hepatitis B patients and its restoration by interferon therapy. Antiviral Therapy 2013;18:877-84.
  • Dahlene N. Fusco, Cynthia Brisac*, Sinu P. John*, Yi-Wen Huang, Christopher R. Chin, Tiao Xie, Hong Zhao, Nikolaus Jilg, Leiliang Zhang, Stephane Chevalier, Daniel Wambua, Wenyu Lin, Lee Peng, Raymond T. Chung, Abraham L. Brass. A genetic screen identifies interferon-alpha effector genes required to suppress hepatitis C virus replication. Gastroenterology 2013;144:1438-49.
  • Yi-Wen Huang, Ting-Chuan Wang, Shih-Chang Lin, Sien-Sing Yang, Ding-Shinn Chen, Jui-Ting Hu, Jia-Horng Kao. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: A nationwide cohort study. Clinical Infectious Diseases 2013;57:1695-702.
  • Yi-Wen Huang, Cheng-Kai Hsu, Shih-Chang Lin, Shu-Chen Wei, Jui-Ting Hu, Han-Yu Chang, Cher-Wei Liang, Ding-Shinn Chen, Pei-Jer Chen, Ping-Ning Hsu, Sien-Sing Yang, Jia-Horng Kao. Reduced Toll-like receptor-9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy. Antiviral Therapy 2014 Mar 12. doi: 10.3851/IMP2762.
  • Yi-Wen Huang, Shoichi Takahashi, Masataka Tsuge, Chi-Ling Chen, Ting-Chuan Wang, Hiromi Abe, Jui-Ting Hu, Ding-Shinn Chen, Sien-Sing Yang, Kazuaki Chayama, Jia-Horng Kao. On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogues therapy. Antiviral Therapy 2014 Apr 16. doi: 10.3851/IMP2777.
  • Yi-Wen Huang, Sien-Sing Yang, Szu-Chieh Fu, Ting-Chuan Wang, Cheng-Kai Hsu, Ding-Shinn Chen, Jui-Ting Hu, Jia-Horng Kao. Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new onset diabetes: A nationwide cohort study. Hepatology 2014 Jun 11. doi: 10.1002/hep.27212.
  • Yi-Wen Huang, Sien-Sing Yang, Jia-Horng Kao. Intrahepatic innate immune sensing in chronic hepatitis B patients. Antiviral Therapy 2014 (In press).
  • Yi-Wen Huang, Kazuaki Chayama, Jia-Horng Kao, Sien-Sing Yang. Detectability and clinical significance of serum hepatitis B virus ribonucleic acid. Hepatobiliary Surgery and Nutrition 2015;4:197-202. doi: 10.3978/j.issn.2304-3881.2014.11.08.
  • Szu-Chieh Fu, Yi-Wen Huang, Ting-Chuan Wang, Jui-Ting Hu, Ding-Shinn Chen, Sien-Sing Yang. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: A nationwide cohort study. Alimentary Pharmacology and Therapeutics 2015;41:1200-1209.
  • Szu-Chieh Fu, Yi-Wen Huang. Editorial: Diabetes and its association with hepatocellular carcinoma in chronic hepatitis B – authors’ reply. Alimentary Pharmacology and Therapeutics 2015;42:118-119.
  • Yi-Wen Huang,# Ting-Chuan Wang,# Sien-Sing Yang, Shyr-Yi Lin, Szu-Chieh Fu, Jui-Ting Hu, Chun-Jen Liu, Jia-Horng Kao, Ding-Shinn Chen. Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: A nationwide cohort study. Alimentary Pharmacology and Therapeutics 2015;42:902-911.
 

【學術演講及專題討論】

Local

  • 11/17/2007 Human leukocyte antigen-DRB1 alleles correlate with clinical outcomes in patients with hepatitis B virus infection in Taiwan National Taiwan University Hospital Medical Research Conference
  • Y07/13/2009 Acute variceal bleeding Department of Emergency Medicine, Cathay General Hospital
  • 12/23/2009 Combination therapy for chronic hepatitis B (GSK)
  • 06/30/2010 What’s new in chronic hepatitis B? (Roche)
  • 08/21/2010 Early diagnosis of hepatocellular carcinoma Liver disease prevention group – patient education Cathay General Hospital Medical Center
  • 10/21/2014 Sprout the Seeds Program – Lecture 1 (Roche) Natural history and pathogenesis of chronic hepatitis B
  • 12/23/2014 Sprout the Seeds Program – Lecture 2 (Roche) Pegylated interferon therapy in chronic hepatitis B
  • 01/14/2015 Management of hepatitis B reactivation during immunosuppressants: guideline recommendation & clinical practice (BMS)
  • 02/04/2015 Sprout the Seeds Program – Lecture 3 (Roche) Response guided therapy of pegylated interferon in chronic hepatitis B and case sharing

National

  • 01/12/2007 The status of alcoholic liver disease in Taiwan Cathay General Hospital – Gastroenterological Society of Taiwan – Taiwan Association for the Study of the Liver (Schering-Plough)
  • 08/15/2009 Analysis of chronic hepatitis C treatment and case discussions Schering-Plough
  • 03/20/2010 Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B Gastroenterological Society of Taiwan
  • 10/02/2010 Effects of glutamine on inflammatory responses in chonic ethanol-fed rats Gastroenterological Society of Taiwan
  • 10/03/2010 Computer-aided diagnosis using high frequency ultrasound in chronic liver disease Taiwan Society of Ultrasound in Medicine
  • 03/22/2014 Hepatitis C treatment update Liver Disease Prevention & Treatment Research Foundation
  • 10/04/2014 HBV treatment, 2014 update 2014 Taiwan Digestive Disease Week & the 2nd Taiwan-Mongolia Joint Forum on Liver Diseases
  • 09/19/2015 Clinical diagnosis and management of non-alcoholic steatohepatitis Liver and GI Tract Clinical and Pathological Symposium
  • 10/05/2015 Non-alcoholic Fatty Liver Disease School of Hepatology, Taiwan Association for the Study of the Liver (TASL) International
  • 03/29/2007 Correlation of HLA-DRB1 polymorphisms and HBV genotypes with clinical courses of HBV carriers. 17th Conference of the Asian Pacific Association for the Study of the Liver, Kyoto, Japan
  • 03/26/2008 Vitamin D receptor polymorphisms correlate with hepatitis flare and e-antigen positivity in hepatitis B carriers 18th Conference of the Asian Pacific Association for the Study of the Liver, Seoul, Korea
  • 06/27/2009 Local practice guidelines and outcomes of chronic hepatitis B in Taiwan 1st Joint university workshop on hepatology, Macau
  • 08/31/2009 Ultrasonography is useful to detect severity of fatty infiltration in alcoholic liver diseases independent of body mass index, liver inflammation, fibrosis and cirrhosis. 12th World Congress of the World Federation for Ultrasound in Medicine and Biology, Sydney, Australia
  • 09/25/2009 Clinical significance of hepatitis B virus replicative intermediate (HBV RNA) during nucleos(t)ide analogues treatment 19th World congress of International Association of Surgeons, Gastroenterologists, and Oncologists, Beijing, China
  • 08/26/2010 Introduction to chronic hepatitis B Methodist Church, Medan, Indonesia
  • 10/23/2010 Acute liver failure in Asia with a high prevalence of chronic hepatitis B 20th World congress of International Association of Surgeons, astroenterologists, and Oncologists, Cairo, Egypt
  • 11/06/2011 Increased risk of cirrhosis in chronic hepatitis B patients who develop diabetes: A population-based study 62th Annual meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, USA
  • 02/16/2012 School of research methodology presentation by alumni of APASL workshop 22nd Conference of the Asian Pacific Association for the Study of the Liver, Taipei, Taiwan
  • 08/25/2012 Alcoholic Liver Disease 2nd Taiwan-China Cross-Strait Liver Disease Forum, Shanghai, China
  • 11/09/2012 Long-term outcomes of interferon versus nucleos(t)ide analogues therapy in chronic hepatitis B patients: A nationwide cohort study 63rd Annual meeting of the American Association for the Study of Liver Diseases, Boston, MA, USA (Hepatology 2012;56:39A).
  • 07/14/2013 Chronic hepatitis B genetics: What the current GWAS data does not tell us? Joint University Workshop on Hepatology V – New era of HBV treatment, Guangzhou, China
  • 07/27/2013 Low serum HBV RNA predicts initial virological response in nucleoside analogue treated chronic hepatitis B patients The 6th Kure International Medical Forum, Kure, Japan
  • 08/03/2014 How to optimally analyze Taiwan National Health Insurance Research Database Joint University Workshop on Hepatology VI – Unmet needs for management of chronic hepatitis, Taitung, Taiwan
  • 10/17/2015 Increased risk of cirrhosis and its decompensation in chronic hepatitis B with new onset hypertension 10th Asia-Pacific Congress of Medical Virology 2015, Taipei, Taiwan

資料更新日期:2020/2/5

商品己加入詢價車

Faded Short Sleeve T-shirts

主治醫師:黃奕文

現職:
國泰綜合醫院肝臟中心主治醫師
台北醫學大學醫學系內科部定副教授
臺大醫學院醫學系內科部定講師